Literature DB >> 16598199

Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis.

K Kawamura1, S Okada, B Li, M Suwa, J Yao, T Morioka, F Gejyo, T Oite.   

Abstract

There is increasing evidence that changes of glomerular hemodynamics or glomerular growth responses may promote the development of glomerulosclerosis. Major problems retarding research progress include lack of suitable experimental animal models, with the exception of the ablation model, and the need for in vivo real-time analysis of glomerular hemodynamics. This study examined the sequence of pathological changes from the viewpoints of microcirculation and histopathology, from the acute stage to the chronic course and the final stage of glomerulosclerosis, using the confocal laser scanning microscope system. There is a marked difference in prognosis between sham-operated (two-kidney) and nephrectomized (one-kidney) rats after injection with anti-Thy-1 antibody. The former reversibly returns to normal and the latter irreversibly go to progressive sclerosis, respectively. The turning point determining the progression of glomerulosclerosis in both groups seemed to be the period from 7 to 14 days after disease induction, when disturbance of local intraglomerular blood flow continued in the one-kidney groups. In conclusion, this study provides the first hemodynamic-based evidence showing that disturbance of intraglomerular microcirculation is a critical marker for progressive glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598199     DOI: 10.1038/sj.ki.5000350

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.

Authors:  Yukiko Nozawa; Ayako Sato; Hoglan Piao; Tetsuo Morioka; Ichiei Narita; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2011-12-07       Impact factor: 2.801

2.  Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.

Authors:  Ayako Sato; Hoglan Piao; Yukiko Nozawa; Tetsuo Morioka; Hiroshi Kawachi; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2012-02-11       Impact factor: 2.801

3.  Glomerular expression of connexin 40 and connexin 43 in rat experimental glomerulonephritis.

Authors:  Tetsuo Morioka; Shinichi Okada; Masaaki Nameta; Fadia Kamal; Nadia T Yanakieva-Georgieva; Jian Yao; Ayako Sato; Honglan Piao; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2012-09-04       Impact factor: 2.801

Review 4.  Exploring the mechanisms of renoprotection against progressive glomerulosclerosis.

Authors:  Takashi Oite
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

5.  Add-On Effect of Angiotensin Receptor Blockade (Candesartan) on Clinical Remission in Active IgA Nephropathy Patients Treated with Steroid Pulse Therapy and Tonsillectomy: a Randomized, Parallel-Group Comparison Trial.

Authors:  Kentaro Kohagura; Hisatomi Arima; Hitoshi Miyasato; Tung-Huei Chang; Masanobu Yamazato; Hiroyuki Kobori; Akira Nishiyama; Kunitoshi Iseki; Yusuke Ohya
Journal:  Kidney Blood Press Res       Date:  2018-05-22       Impact factor: 2.687

6.  Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats.

Authors:  Klaudia M Maksymiuk; Mateusz Szudzik; Marta Gawryś-Kopczyńska; Maksymilian Onyszkiewicz; Emilia Samborowska; Izabella Mogilnicka; Marcin Ufnal
Journal:  J Transl Med       Date:  2022-10-15       Impact factor: 8.440

7.  Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.

Authors:  Heather S Bevan; Sadie C Slater; Hayley Clarke; Paul A Cahill; Peter W Mathieson; Gavin I Welsh; Simon C Satchell
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.